Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jenscare Scientific CoHKSE:09877 +0.60%33 EBITDA Margin % is -120.02% as of Dec. 2025. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Jenscare Scientific Co ranks worse than 89.31% on this metric.
Jenscare Scientific Co (HKSE:09877) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Jenscare Scientific Co EBITDA Margin % Related Terms
Jenscare Scientific Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Jenscare Scientific Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:09877 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Jenscare Scientific Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co (HKSE:09877) has a EBITDA Margin % of -120.02% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jenscare Scientific Co and its competitors. According to the industry distribution chart, Jenscare Scientific Co ranks #727 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 89.3%.
Is Jenscare Scientific Co's EBITDA Margin % too high?
Jenscare Scientific Co's current EBITDA Margin % is -120.02%. Based on the distribution chart, Jenscare Scientific Co ranks #727 out of 814 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Jenscare Scientific Co ranks #727 out of 814 companies for EBITDA Margin %. This places Jenscare Scientific Co in the lower half of its industry. The industry median EBITDA Margin % is 7.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.67, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Jenscare Scientific Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jenscare Scientific Co's current EBITDA Margin % is -120.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current EBITDA Margin % of -120.02%. The current EBITDA Margin % is -120.02%. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current EBITDA Margin % is -120.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score
Get the complete analysis for HKSE:09877
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09877 has been successfully added to your 
